AUTOIMMUNE HEPATITIS
Clinical trials for AUTOIMMUNE HEPATITIS explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEPATITIS trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested to tame overactive liver disease
Disease control CompletedThis study tested whether adding an experimental drug called zetomipzomib to standard steroid treatment could better control autoimmune hepatitis. It involved 24 adults whose liver disease was still active despite standard care. Participants received either the new drug or a plac…
Matched conditions: AUTOIMMUNE HEPATITIS
Phase: PHASE2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC
-
New drug tested for Hard-to-Treat liver disease
Disease control CompletedThis study tested a new drug called VAY736 for adults with autoimmune hepatitis, a condition where the body's immune system attacks the liver. It was for patients whose disease was not fully controlled by standard medications or who couldn't tolerate them. Researchers compared di…
Matched conditions: AUTOIMMUNE HEPATITIS
Phase: PHASE2, PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists test new Scan's reliability for spotting liver trouble
Diagnosis CompletedThis study tested how consistent and reliable a special type of MRI scan, called LiverMultiScan, is for measuring liver health. Researchers scanned 61 volunteers with various liver conditions on different MRI machines to see if the results were the same each time. The goal is to …
Matched conditions: AUTOIMMUNE HEPATITIS
Sponsor: Perspectum • Aim: Diagnosis
Last updated Mar 25, 2026 14:08 UTC